Market Overview:
The global vacuum-assisted biopsy devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, technological advancements in vacuum-assisted biopsy devices, and rising demand for minimally invasive procedures. Based on type, the global vacuum-assisted biopsy devices market is segmented into 9-12G, 12G segments. The 9-12G segment is expected to account for the largest share of the global market in 2018 owing to its high adoption rates across hospitals and diagnostic centers. By application, the hospitals segment is expected to account for the largest share of the global market in 2018 followed by academic and research institutes and diagnostic and imaging centers segments respectively.
Product Definition:
A vacuum-assisted biopsy device (VABI) is a medical device that uses a vacuum to suck tissue samples from the body. The importance of VABI devices lies in their ability to collect tissue samples with minimal invasiveness and without causing damage to the surrounding tissue. This makes them ideal for use in biopsies, which are procedures used to test for cancer and other diseases.
9-12G:
9-12G is a radiopharmaceutical used for PET (Positron Emission Tomography) scan. It is an artificial chemical made by combining Carbon-14 with Gallium andium, which then emits 19F, 28SiO2 and 36Cl3 along with a beam of gamma rays. The main use of this radiopharmaceutical is to enable doctors to detect cancer cells in the body using high accuracy and precision.
The global market for vacuum-assisted biopsy devices was valued at USD 1.6 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence of cancer across the globe, rising demand for early diagnostic procedures, and technological advancements are some major factors driving growth during the forecast period.
Application Insights:
Based on application, the global market is segmented into hospitals, academic and research institutes, diagnostic and imaging centers, and others. The hospitals segment dominated the overall market in terms of revenue in 2017. This can be attributed to factors such as increasing patient admissions due to growing geriatric population & unhealthy lifestyle coupled with rising prevalence of cancer across the globe.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of manufacturers, suppliers, and distributors in this region. Moreover, increasing prevalence of cancer is also one of the major factors responsible for its largest share. According to statistics published by American Cancer Society (ACS), it was estimated that 1 in 2 men and 1 in 3 women will be diagnosed with cancer during their lifetime here – more than 6 million new cases were estimated to have been diagnosed as of 2016.
Asia Pacific is anticipated to grow at an exponential rate throughout the forecast period owing to increasing incidence rates coupled with growing target population base especially from China & India thereby boosting growth opportunities across this region over the forecast period.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for vacuum-assisted biopsy devices market. According to the World Health Organization (WHO), in 2012, there were 14 million new cases of cancer and 8.2 million deaths due to cancer worldwide. This number is expected to increase by about 70% over the next two decades, accounting for nearly 21 million new cases and 13 million deaths each year by 2030. This will create a large demand for vacuum-assisted biopsy devices as they are used for diagnosis and treatment of various types of cancers.
- Technological advancements: The technological advancements in vacuum-assisted biopsy devices are another major growth driver for this market. These advancements have led to the development of novel products with enhanced features that offer better performance and accuracy than traditional methods such as needle aspiration or core needle biopsy (CNB). For instance, in 2016, Hologic Corporation launched its Selenia Dimensions system – a next generation 3D mammography system that offers high quality images with low radiation exposure levels and helps detect early stage breast cancers with greater accuracy than traditional 2D mammography systems . Such technological advances are likely to boost the demand for vacuum-assisted biopsy devices in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Vacuum-assisted Biopsy Devices Market Research Report
By Type
9-12G, <9G, >12G
By Application
Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers
By Companies
BD, Mammotome, Hologic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Vacuum-assisted Biopsy Devices Market Report Segments:
The global Vacuum-assisted Biopsy Devices market is segmented on the basis of:
Types
9-12G, <9G, >12G
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD
- Mammotome
- Hologic
Highlights of The Vacuum-assisted Biopsy Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 9-12G
- <9G
- >12G
- By Application:
- Hospitals
- Academic and Research Institutes
- Diagnostic and Imaging Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vacuum-assisted Biopsy Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A vacuum-assisted biopsy device is a medical instrument that uses a vacuum to remove tissue from an area of the body. This device can be used to collect cells or other samples from the skin, muscle, or other areas of the body.
Some of the key players operating in the vacuum-assisted biopsy devices market are BD, Mammotome, Hologic.
The vacuum-assisted biopsy devices market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Vacuum-assisted Biopsy Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Vacuum-assisted Biopsy Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Vacuum-assisted Biopsy Devices Market - Supply Chain
4.5. Global Vacuum-assisted Biopsy Devices Market Forecast
4.5.1. Vacuum-assisted Biopsy Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Vacuum-assisted Biopsy Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Vacuum-assisted Biopsy Devices Market Absolute $ Opportunity
5. Global Vacuum-assisted Biopsy Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Type
5.3.1. 9-12G
5.3.2. <9G
5.3.3. >12G
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Vacuum-assisted Biopsy Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Academic and Research Institutes
6.3.3. Diagnostic and Imaging Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Vacuum-assisted Biopsy Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Vacuum-assisted Biopsy Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Vacuum-assisted Biopsy Devices Demand Share Forecast, 2019-2026
9. North America Vacuum-assisted Biopsy Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Academic and Research Institutes
9.4.3. Diagnostic and Imaging Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Type
9.7.1. 9-12G
9.7.2. <9G
9.7.3. >12G
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Vacuum-assisted Biopsy Devices Demand Share Forecast, 2019-2026
10. Latin America Vacuum-assisted Biopsy Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Academic and Research Institutes
10.4.3. Diagnostic and Imaging Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Type
10.7.1. 9-12G
10.7.2. <9G
10.7.3. >12G
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Vacuum-assisted Biopsy Devices Demand Share Forecast, 2019-2026
11. Europe Vacuum-assisted Biopsy Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Academic and Research Institutes
11.4.3. Diagnostic and Imaging Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Type
11.7.1. 9-12G
11.7.2. <9G
11.7.3. >12G
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Vacuum-assisted Biopsy Devices Demand Share, 2019-2026
12. Asia Pacific Vacuum-assisted Biopsy Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Academic and Research Institutes
12.4.3. Diagnostic and Imaging Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Type
12.7.1. 9-12G
12.7.2. <9G
12.7.3. >12G
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Vacuum-assisted Biopsy Devices Demand Share, 2019-2026
13. Middle East & Africa Vacuum-assisted Biopsy Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Academic and Research Institutes
13.4.3. Diagnostic and Imaging Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Vacuum-assisted Biopsy Devices Market Size and Volume Forecast by Type
13.7.1. 9-12G
13.7.2. <9G
13.7.3. >12G
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Vacuum-assisted Biopsy Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Vacuum-assisted Biopsy Devices Market: Market Share Analysis
14.2. Vacuum-assisted Biopsy Devices Distributors and Customers
14.3. Vacuum-assisted Biopsy Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BD
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Mammotome
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Hologic
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook